Literature DB >> 23422746

Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes.

Joseph C Mudd1, Patrick Murphy, Maura Manion, Robert Debernardo, Jeffrey Hardacre, John Ammori, Gareth A Hardy, Clifford V Harding, Ganapati H Mahabaleshwar, Mukesh K Jain, Jeffrey M Jacobson, Ari D Brooks, Sharon Lewis, Timothy W Schacker, Jodi Anderson, Elias K Haddad, Rafael A Cubas, Benigno Rodriguez, Scott F Sieg, Michael M Lederman.   

Abstract

The determinants of HIV-1-associated lymphadenopathy are poorly understood. We hypothesized that lymphocytes could be sequestered in the HIV-1+ lymph node (LN) through impairments in sphingosine-1-phosphate (S1P) responsiveness. To test this hypothesis, we developed novel assays for S1P-induced Akt phosphorylation and actin polymerization. In the HIV-1+ LN, naïve CD4 T cells and central memory CD4 and CD8 T cells had impaired Akt phosphorylation in response to S1P, whereas actin polymerization responses to S1P were impaired dramatically in all LN maturation subsets. These defects were improved with antiretroviral therapy. LN T cells expressing CD69 were unable to respond to S1P in either assay, yet impaired S1P responses were also seen in HIV-1+ LN T cells lacking CD69 expression. Microbial elements, HIV-1, and interferon α - putative drivers of HIV-1 associated immune activation all tended to increase CD69 expression and reduce T-cell responses to S1P in vitro. Impairment in T-cell egress from lymph nodes through decreased S1P responsiveness may contribute to HIV-1-associated LN enlargement and to immune dysregulation in a key organ of immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422746      PMCID: PMC3624937          DOI: 10.1182/blood-2012-07-445783

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

Authors:  R P Bucy; R D Hockett; C A Derdeyn; M S Saag; K Squires; M Sillers; R T Mitsuyasu; J M Kilby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

2.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.

Authors:  Pedro J Gonzalez-Cabrera; Timothy Hla; Hugh Rosen
Journal:  J Biol Chem       Date:  2007-01-10       Impact factor: 5.157

4.  Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration.

Authors:  Wengang Wang; Markus H Graeler; Edward J Goetzl
Journal:  FASEB J       Date:  2005-07-26       Impact factor: 5.191

5.  Kruppel-like factor 2 regulates thymocyte and T-cell migration.

Authors:  Corey M Carlson; Bart T Endrizzi; Jinghai Wu; Xiaojie Ding; Michael A Weinreich; Elizabeth R Walsh; Maqsood A Wani; Jerry B Lingrel; Kristin A Hogquist; Stephen C Jameson
Journal:  Nature       Date:  2006-07-20       Impact factor: 49.962

6.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Authors:  Angélique Biancotto; Jean-Charles Grivel; Sarah J Iglehart; Christophe Vanpouille; Andrea Lisco; Scott F Sieg; Robert Debernardo; Kristen Garate; Benigno Rodriguez; Leonid B Margolis; Michael M Lederman
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

7.  Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction.

Authors:  Diana M Brainard; Andrew M Tager; Joseph Misdraji; Nicole Frahm; Mathias Lichterfeld; Rika Draenert; Christian Brander; Bruce D Walker; Andrew D Luster
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

8.  CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

Authors:  Lawrence R Shiow; David B Rosen; Nadezda Brdicková; Ying Xu; Jinping An; Lewis L Lanier; Jason G Cyster; Mehrdad Matloubian
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

9.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

10.  A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress.

Authors:  César Nombela-Arrieta; Thorsten R Mempel; Silvia F Soriano; Irina Mazo; Matthias P Wymann; Emilio Hirsch; Carlos Martínez-A; Yoshinori Fukui; Ulrich H von Andrian; Jens V Stein
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

View more
  22 in total

1.  Identification and characterization of HIV-specific resident memory CD8+ T cells in human lymphoid tissue.

Authors:  Marcus Buggert; Son Nguyen; Gonzalo Salgado-Montes de Oca; Bertram Bengsch; Samuel Darko; Amy Ransier; Emily R Roberts; Daniel Del Alcazar; Irene Bukh Brody; Laura A Vella; Lalit Beura; Sathi Wijeyesinghe; Ramin S Herati; Perla M Del Rio Estrada; Yuria Ablanedo-Terrazas; Leticia Kuri-Cervantes; Alberto Sada Japp; Sasikanth Manne; Shant Vartanian; Austin Huffman; Johan K Sandberg; Emma Gostick; Gregory Nadolski; Guido Silvestri; David H Canaday; David A Price; Constantinos Petrovas; Laura F Su; Golnaz Vahedi; Yoav Dori; Ian Frank; Maxim G Itkin; E John Wherry; Steven G Deeks; Ali Naji; Gustavo Reyes-Terán; David Masopust; Daniel C Douek; Michael R Betts
Journal:  Sci Immunol       Date:  2018-06-01

Review 2.  Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.

Authors:  Irina V Tiper; James E East; Priyanka B Subrahmanyam; Tonya J Webb
Journal:  Pathog Dis       Date:  2016-06-27       Impact factor: 3.166

3.  Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery.

Authors:  Rachel S Resop; Marc Douaisi; Joshua Craft; Loes C M Jachimowski; Bianca Blom; Christel H Uittenbogaart
Journal:  J Allergy Clin Immunol       Date:  2016-04-04       Impact factor: 10.793

4.  Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.

Authors:  Thao P Nguyen; Doug A Bazdar; Joseph C Mudd; Michael M Lederman; Clifford V Harding; Gareth A Hardy; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2015-03-17       Impact factor: 4.962

5.  HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.

Authors:  Andrew T Hale; Chris T Longenecker; Ying Jiang; Sara M Debanne; Danielle E Labatto; Norma Storer; Anne Hamik; Grace A McComsey
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

Review 6.  Residual immune dysregulation syndrome in treated HIV infection.

Authors:  Michael M Lederman; Nicholas T Funderburg; Rafick P Sekaly; Nichole R Klatt; Peter W Hunt
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

7.  JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4.

Authors:  Chuntang Fu; Qingtian Li; Jia Zou; Changsheng Xing; Mei Luo; Bingnan Yin; Junjun Chu; Jiaming Yu; Xin Liu; Helen Y Wang; Rong-Fu Wang
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

8.  The interferon paradox: can inhibiting an antiviral mechanism advance an HIV cure?

Authors:  Steven G Deeks; Pamela M Odorizzi; Rafick-Pierre Sekaly
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

Review 9.  Exit Strategies: S1P Signaling and T Cell Migration.

Authors:  Audrey Baeyens; Victoria Fang; Cynthia Chen; Susan R Schwab
Journal:  Trends Immunol       Date:  2015-12       Impact factor: 16.687

10.  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study.

Authors:  Juan G Sierra-Madero; Susan Ellenberg; Mohammed S Rassool; Ann Tierney; Pablo F Belaunzarán-Zamudio; Alondra López-Martínez; Alicia Piñeirúa-Menéndez; Luis J Montaner; Livio Azzoni; César Rivera Benítez; Irini Sereti; Jaime Andrade-Villanueva; Juan L Mosqueda-Gómez; Benigno Rodriguez; Ian Sanne; Michael M Lederman
Journal:  Lancet HIV       Date:  2014-11-01       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.